Arbutus Biopharma Aktie
3,72
EUR
+0,12
EUR
+3,22
%
4,47
USD
+0,12
USD
+2,76
%
Werbung
Arbutus Biopharma Aktie Analyse
| 16.10.18 | Arbutus Biopharma Buy | B. Riley FBR | |
| 15.10.18 | Arbutus Biopharma Neutral | Wedbush Morgan Securities Inc. | |
| 12.10.18 | Arbutus Biopharma Buy | Chardan Capital Markets | |
| 06.07.18 | Arbutus Biopharma Neutral | B. Riley FBR, Inc. | |
| 19.03.18 | Arbutus Biopharma Neutral | Wedbush Morgan Securities Inc. | |
| 19.03.18 | Arbutus Biopharma Buy | Chardan Capital Markets | |
| 05.01.18 | Arbutus Biopharma Buy | B. Riley FBR, Inc. | |
| 04.04.17 | Arbutus Biopharma Buy | Chardan Capital Markets | |
|
Werbung
|
|||
| 01.02.17 | Arbutus Biopharma Outperform | Wedbush Morgan Securities Inc. | |
| 13.12.16 | Arbutus Biopharma Neutral | Chardan Capital Markets | |
| 30.11.16 | Arbutus Biopharma Buy | Chardan Capital Markets | |
| 14.10.16 | Arbutus Biopharma Neutral | Chardan Capital Markets | |
| 08.07.16 | Arbutus Biopharma Sell | Chardan Capital Markets | |
| 16.06.16 | Arbutus Biopharma Neutral | Chardan Capital Markets | |
| 16.05.16 | Arbutus Biopharma Sell | Chardan Capital Markets | |
| 06.11.15 | Arbutus Biopharma Outperform | RBC Capital Markets | |
Werbung
Werbung